Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7209
Source ID: NCT06132477
Associated Drug: Glp-1 Receptor Agonist
Title: Impact GLP-1 Agonists Following Bariatric
Acronym:
Status: RECRUITING
Study Results: NO
Results:
Conditions: Morbid Obesity|Metabolic Syndrome|Diabetes Mellitus|Hypertension|Obstructive Sleep Apnea of Adult
Interventions: DRUG: GLP-1 receptor agonist
Outcome Measures: Primary: Effect of GLP1-RA on weight loss, To investigate the effects of GLP1-RAs on weight loss reflected as change in BMI (kg per meter sq) in patients undergoing metabolic surgery, 6 months|Effect of GLP1-RA on circulating bile acids and metabolites, Determine the impact of GLP1-RA on circulating bile acids and other metabolites, 6 months|Effector of GLP1-RA on gut microbiome diversity, To determine the impact of GLP1-RAs after bariatric surgery on changes in the gut microbiome, 6 months|Effect of GLP1-RA on satiety and hunger, To assess the impact of GLP-1 agonists on satiety and hunger in patients who undergo metabolic surgery. Scale will be a validated scoring system, "Daily Eats Questionnaire," with scores ranging from 0-10, with a 0 indicating no hunger, and 10 indicating extreme hunger, 6 months|Effect of GLP1-RA on Glycemic control, HGBA1C levels will be measured at 3 and 6 months after surgery to determine if HGBA1C drops more in patients maintained on GLP1-RA, 6 months |
Sponsor/Collaborators: Sponsor: University of Missouri-Columbia | Collaborators: American Society for Metabolic and Bariatric Surgery
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 150
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2024-02-01
Completion Date: 2028-07
Results First Posted:
Last Update Posted: 2024-09-20
Locations: University of Missouri Hospital, Columbia, Missouri, 65201, United States
URL: https://clinicaltrials.gov/show/NCT06132477